by Study Scavenger | Jan 25, 2019 | Study Scavenger Clinical Trial Recruitment Platform
CorMatrix® Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announced FDA approval of an early feasibility study IDE to evaluate the safety and feasibility of the Cor™ TRICUSPID ECM® cardiac valve for...by Study Scavenger | Jan 25, 2019 | Study Scavenger Clinical Trial Recruitment Platform
-Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces that two presentations highlighting the potential of Advaxis vectors to generate T cell responses to a...by Study Scavenger | Jan 25, 2019 | Study Scavenger Clinical Trial Recruitment Platform
ArQule, Inc.’s ARQL, -1.67% partner, Basilea Pharmaceutica Ltd. (six:BSLN), announced today that it entered into a collaboration with Roche (six:RO)(six:ROG) to explore a combination of derazantinib (BAL087) and Roche’s PD-L1-blocking immune-checkpoint inhibitor,...by Study Scavenger | Jan 25, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated the second Phase 1 clinical trial with CTP-692, a novel deuterium-modified form of D-serine being developed as an adjunctive treatment for schizophrenia. The Phase 1 single-ascending...by Study Scavenger | Jan 25, 2019 | Study Scavenger Clinical Trial Recruitment Platform
The WVU Cancer Institute is enrolling patients in an innovative clinical trial to treat ovarian cancer. Valerie Galvan Turner, M.D., gynecologic oncologist at the WVU Cancer Institute, will help lead the trial to evaluate the efficacy of varying dosages and...